Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q8WWX8: Variant p.Phe258Leu

Sodium/myo-inositol cotransporter 2
Gene: SLC5A11
Feedback?
Variant information Variant position: help 258 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Phenylalanine (F) to Leucine (L) at position 258 (F258L, p.Phe258Leu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and aromatic (F) to medium size and hydrophobic (L) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 258 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 675 The length of the canonical sequence.
Location on the sequence: help LALASNRSENSSCGLPREDA F HIFRDPLTSDLPWPGVLFGM The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         LALASNRSENSSCGLPREDAFHIFRDPLTSDLPWPGVLFGM

Mouse                         LALASNRSENSSCGLPREDAFHIFRDPLTSDLPWPGILFGM

Rat                           LALASNRSENSSCGLPREDAFHIFRDPLTSDLPWPGILFGM

Pig                           LALASNRSGNSSCGLPREDAFHIFRDPLTSDLPWPGILFGM

Bovine                        LAMASNRSGNSSCGLPREDAFHIFRDPVTSDLPWPGILFGM

Rabbit                        LALPSNRSENSSCGLPREDAFHLFRDPLTSDLPWPGILFGM

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 675 Sodium/myo-inositol cotransporter 2
Topological domain 230 – 272 Extracellular
Alternative sequence 223 – 302 FAAVGGMEGLKEKYFLALASNRSENSSCGLPREDAFHIFRDPLTSDLPWPGVLFGMSIPSLWYWCTDQVIVQRTLAAKNL -> DCPADSGCQEPVPCQRRCSDGCIPEGAAPLHNGVPWDGQPHPLPRSSGLCRSRDLPEDLQQPLRLFGHRVSQTRAGTPAH. In isoform 6.



Literature citations
New human sodium/glucose cotransporter gene (KST1): identification, characterization, and mutation analysis in ICCA (infantile convulsions and choreoathetosis) and BFIC (benign familial infantile convulsions) families.
Roll P.; Massacrier A.; Pereira S.; Robaglia-Schlupp A.; Cau P.; Szepetowski P.;
Gene 285:141-148(2002)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2); TISSUE SPECIFICITY; VARIANTS ALA-182; LEU-258 AND ILE-526;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.